Total Funding
76
85
Total FundingConvertible Note raised
Growth Score
-2 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
114259
Polyceutix transforms cancer treatment by unleashing the full power of the immune system.
About the Company
Polyceutix aims to treat muscle-invasive bladder cancer by employing AASTY-TLR, a novel immunomodulatory substance developed at the nexus of immunology and materials science. The copolymer AASTY-TLR is injected into tumors, where it breaks down the membrane proteins and lipid bilayers into polymer-lipid particles.
